Dudediligence.

United Therapeutics Corporation

UTHRNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$748.9MSep ’24$735.9MDec ’24$794.4MMar ’25$798.6MJun ’25$799.5MSep ’25$790.2MDec ’25$781.5MMar ’26$783.3MJun ’26
Net income, by quarter
$309.1MSep ’24$301.3MDec ’24$322.2MMar ’25$309.5MJun ’25$338.7MSep ’25$364.3MDec ’25$274.9MMar ’26$333.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.69B$1.94B$2.33B$2.88B$3.18B
Gross profit$1.56B$1.78B$2.07B$2.57B$2.80B
Operating income$555.9M$979.7M$1.18B$1.38B$1.49B
Net income$475.8M$727.3M$984.8M$1.20B$1.33B
Operating cash flow$598.2M$802.5M$978.0M$1.33B$1.56B
Free cash flow$477.4M$663.7M$747.6M$1.08B$1.04B
Cash$894.8M$961.2M$1.21B$1.70B$1.56B
Shares outstanding45.1M46.0M47.0M44.8M43.6M